PDTCM: a systems pharmacology platform of traditional Chinese medicine for psoriasis

References

• Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263–271.
   PubMed Web of Science ®Google Scholar
• Elder JT, Bruce AT, Gudjonsson JE, et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol. 2010;130:1213–1226.
   PubMed Web of Science ®Google Scholar
• Christophers E. Psoriasis – epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314–320.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866–873.
   PubMed Web of Science ®Google Scholar
• Espinoza LR, Cuellar ML, Silveira LH. Psoriatic arthritis. Curr Opin Rheumatol. 1992;4:470–478.
   PubMedGoogle Scholar
• He Z, Lu C, Ou A, et al. Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis. Health Qual Life Outcomes. 2012;10:37.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311–335.
   PubMed Web of Science ®Google Scholar
• Harvey AL. Natural products in drug discovery. Drug Discov Today. 2008;13:894–901.
   PubMed Web of Science ®Google Scholar
• Garcia-Perez ME, Stevanovic T, Poubelle PE. New therapies under development for psoriasis treatment. Curr Opin Pediatr. 2013;25:480–487.
   PubMed Web of Science ®Google Scholar
• Nijsten T, Margolis DJ, Feldman SR, et al. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol. 2005;52:434–444.
   PubMed Web of Science ®Google Scholar
• Zhang M, Brenneman SK, Carter CT, et al. Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis. Patient Prefer Adherence. 2015;8:777–784.
   Web of Science ®Google Scholar
• D'Souza LS, Payette MJ. Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis. J Am Acad Dermatol. 2015;72:589–598.
   PubMed Web of Science ®Google Scholar
• Yu JJ, Zhang CS, Zhang AL, et al. Add-on effect of Chinese herbal medicine bath to phototherapy for psoriasis vulgaris: a systematic review. Evid Based Complement Alternat Med. 2013;2013:673078.
   PubMed Web of Science ®Google Scholar
• Zhang CS, Yu JJ, Parker S, et al. Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review. Int J Dermatol. 2014;53:1305–1318.
   PubMed Web of Science ®Google Scholar
• Jiang M, Yang J, Zhang C, et al. Clinical studies with traditional Chinese medicine in the past decade and future research and development. Planta Med. 2010;76:2048–2064.
   PubMed Web of Science ®Google Scholar
• Lu C, Deng J, Li L, et al. Application of metabolomics on diagnosis and treatment of patients with psoriasis in traditional Chinese medicine. Biochim Biophys Acta. 2014;1844:280–288.
   PubMed Web of Science ®Google Scholar
• Koo J, Arain S. Traditional Chinese medicine in dermatology. Clin Dermatol. 1999;17:21–27.
   PubMed Web of Science ®Google Scholar
• Mishra BB, Tiwari VK. Natural products: an evolving role in future drug discovery. Eur J Med Chem. 2011;46:4769–4807.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ. Natural product drug discovery in the next millennium. Pharm Biol. 2001;39(Suppl 1):8–17.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70:461–477.
   PubMed Web of Science ®Google Scholar
• Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4:206–220.
   PubMed Web of Science ®Google Scholar
• Han L, Sun J, Lu CJ, et al. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-kappaB expression. Int Immunopharmacol. 2017;44:226–233.
   PubMed Web of Science ®Google Scholar
• Yao DN, Lu CJ, Wen ZH, et al. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial. Trials. 2016;17:140.
   PubMed Web of Science ®Google Scholar
• Shen J, Xu X, Cheng F, et al. Virtual screening on natural products for discovering active compounds and target information. Curr Med Chem. 2003;10:2327–2342.
   PubMed Web of Science ®Google Scholar
• He M, Yan X, Zhou J, et al. Traditional Chinese medicine database and application on the Web. J Chem Inf Comput Sci. 2001;41:273–277.
   PubMedGoogle Scholar
• Qiao X, Hou T, Zhang W, et al. A 3D structure database of components from Chinese traditional medicinal herbs. J Chem Inf Comput Sci. 2002;42:481–489.
   PubMedGoogle Scholar
• Gu J, Gui Y, Chen L, et al. Use of natural products as chemical library for drug discovery and network pharmacology. PLoS One. 2013;8:e62839.
   PubMed Web of Science ®Google Scholar
• Knox C, Law V, Jewison T, et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011;39:D1035–D1041. (Database issue)
   PubMed Web of Science ®Google Scholar
• Yang H, Qin C, Li YH, et al. Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information. Nucleic Acids Res. 2016;44:D1069–D1074.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S, Sato Y, et al. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40:D109–D114. (Database issue)
   PubMed Web of Science ®Google Scholar
• Kalyaanamoorthy S, Chen YP. Structure-based drug design to augment hit discovery. Drug Discov Today. 2011;16:831–839.
   PubMed Web of Science ®Google Scholar
• Jiang X, Kumar K, Hu X, et al. DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. Chem Cent J. 2008;2:18.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
   PubMed Web of Science ®Google Scholar
• Abagyan R, Totrov M. High-throughput docking for lead generation. Curr Opin Chem Biol. 2001;5:375–382.
   PubMed Web of Science ®Google Scholar
• McInnes C. Virtual screening strategies in drug discovery. Curr Opin Chem Biol. 2007;11:494–502.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang B, Zhang N. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol. 2011;5(Suppl 1):S10.
   PubMed Web of Science ®Google Scholar
• Chen SD, Lu CJ, Zhao RZ. Identification and quantitative characterization of PSORI-CM01, a Chinese medicine formula for psoriasis therapy, by liquid chromatography coupled with an LTQ Orbitrap mass spectrometer. Molecules. 2015;20:1594–1609.
   PubMed Web of Science ®Google Scholar
• El-Elimat T, Zhang X, Jarjoura D, et al. Chemical diversity of metabolites from fungi, cyanobacteria, and plants relative to FDA-approved anticancer agents. ACS Med Chem Lett. 2012;3:645–649.
   PubMed Web of Science ®Google Scholar
• Dobson CM. Chemical space and biology. Nature. 2004;432:824–828.
   PubMed Web of Science ®Google Scholar
• Rosen J, Gottfries J, Muresan S, et al. Novel chemical space exploration via natural products. J Med Chem. 2009;52:1953–1962.
   PubMed Web of Science ®Google Scholar
• Bauer A, Bronstrup M. Industrial natural product chemistry for drug discovery and development. Nat Prod Rep. 2014;31:35–60.
   PubMed Web of Science ®Google Scholar
• Wenderski TA, Stratton CF, Bauer RA, et al. Principal component analysis as a tool for library design: a case study investigating natural products, brand-name drugs, natural product-like libraries, and drug-like libraries. Methods Mol Biol. 2015;1263:225–242.
   PubMedGoogle Scholar
• Wenlock MC, Austin RP, Barton P, et al. A comparison of physiochemical property profiles of development and marketed oral drugs. J Med Chem. 2003;46:1250–1256.
   PubMed Web of Science ®Google Scholar
• Hughes JD, Blagg J, Price DA, et al. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett. 2008;18:4872–4875.
   PubMed Web of Science ®Google Scholar
• Bade R, Chan HF, Reynisson J. Characteristics of known drug space. Natural products, their derivatives and synthetic drugs. Eur J Med Chem. 2010;45:5646–5652.
   PubMed Web of Science ®Google Scholar
• Leeson P. Drug discovery: Chemical beauty contest. Nature. 2012;481:455–456.
   PubMed Web of Science ®Google Scholar
• Clardy J, Walsh C. Lessons from natural molecules. Nature. 2004;432:829–837.
   PubMed Web of Science ®Google Scholar
• Taboureau O, Baell JB, Fernandez-Recio J, et al. Established and emerging trends in computational drug discovery in the structural genomics era. Chem Biol. 2012;19:29–41.
   PubMed Web of Science ®Google Scholar
• Lavie G, Meruelo D, Aroyo K, et al. Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: potential for treatment of T cell-mediated diseases. Int Immunol. 2000;12:479–486.
   PubMed Web of Science ®Google Scholar
• Najafizadeh P, Hashemian F, Mansouri P, et al. The evaluation of the clinical effect of topical St Johns wort (Hypericum perforatum L.) in plaque type psoriasis vulgaris: a pilot study. Australas J Dermatol. 2012;53:131–135.
   PubMed Web of Science ®Google Scholar
• Eldahshan OA, Abdel-Daim MM. Phytochemical study, cytotoxic, analgesic, antipyretic and anti-inflammatory activities of Strychnos nux-vomica. Cytotechnology. 2015;67:831–844.
   PubMed Web of Science ®Google Scholar
• Yuan XY, Liu W, Zhang P, et al. Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice. Eur J Pharmacol. 2010;629:147–152.
   PubMed Web of Science ®Google Scholar
• Vijayalakshmi A, Ravichandiran V, Malarkodi V, et al. Screening of flavonoid “quercetin” from the rhizome of Smilax china Linn. for anti-psoriatic activity. Asian Pac J Trop Biomed. 2012;2:269–275.
   PubMedGoogle Scholar